BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Hikma Pharmaceuticals 

13 Hanover Square

London    W1S 1HL  United Kingdom
Phone: 44-0-20-7399-2760 Fax: 44-0-20-7399-2761


SEARCH JOBS




Industry
Biotechnology






 Company News
Hikma Pharmaceuticals (HIK.L) Falls On FDA Warning For Portugal Plant 10/24/2014 5:53:54 AM
Hikma Pharmaceuticals Enters Partnership With Eisai Company, Ltd. (ESALY.PK) For Distribution Of First-In-Class Epilepsy Treatment Fycompa® In Middle East 10/13/2014 10:11:49 AM
Hikma Pharmaceuticals Eyeing $1 Billion Bid For U.S. Rival CorePharma LLC 9/29/2014 6:46:55 AM
Hikma Pharmaceuticals Completes Acquisition Of Ben Venue Laboratories Manufacturing Site 9/17/2014 10:44:16 AM
Hikma Pharmaceuticals Delivers Excellent First Half Results With 16% Revenue Growth And 44% Increase In Adjusted EPS 8/20/2014 9:23:31 AM
Hikma Pharmaceuticals Buys Ben Venue Laboratories's Generic Manufacturing Site 7/24/2014 6:37:28 AM
Hikma Pharmaceuticals Completes The Acquisition Of Assets Of Bedford Laboratories 7/15/2014 1:11:50 PM
Hikma Pharmaceuticals Buys Boehringer Ingelheim Corporation Injectable Drugs Business Bedford Laboratories For Up To $300 Million 5/28/2014 6:37:56 AM
Hikma Pharmaceuticals: Interim Management Statement 5/15/2014 8:58:57 AM
Hikma Pharmaceuticals Says FDA Lifts Warning On Eatontown Facility 4/2/2014 7:03:59 AM
123456